Literature DB >> 6882949

Platelet-activating factor increases pulmonary microvascular permeability and induces pulmonary edema. A preliminary report.

M Mojarad, Y Hamasaki, S I Said.   

Abstract

Platelet-activating factor, a naturally occurring lipid that is released from leukocytes and alveolar macrophages, increased the flow of protein-rich lymph from the lungs and induced pulmonary edema in dogs when given in picomolar doses. The pulmonary edema was due to increased microvascular permeability, probably secondary to endothelial cell injury. These observations suggest that platelet-activating factor may be a mediator of high-permeability pulmonary edema in the "respiratory distress syndrome" complicating acute lung injury.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6882949

Source DB:  PubMed          Journal:  Bull Eur Physiopathol Respir        ISSN: 0395-3890


  10 in total

1.  Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients.

Authors:  Daryl J Kor; Jason Erlich; Michelle N Gong; Michael Malinchoc; Rickey E Carter; Ognjen Gajic; Daniel S Talmor
Journal:  Crit Care Med       Date:  2011-11       Impact factor: 7.598

2.  PAF-acether induced cardiac dysfunction in the isolated perfused guinea pig heart.

Authors:  G L Stahl; D J Lefer; A M Lefer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-10       Impact factor: 3.000

3.  Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.

Authors:  S W Chang; C O Feddersen; P M Henson; N F Voelkel
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

4.  Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study.

Authors:  Jason M Erlich; Daniel S Talmor; Rodrigo Cartin-Ceba; Ognjen Gajic; Daryl J Kor
Journal:  Chest       Date:  2010-08-05       Impact factor: 9.410

5.  Bronchial and vascular effects of Paf in the rat isolated lung are completely blocked by WEB 2086, a novel specific Paf antagonist.

Authors:  J Casals-Stenzel; J Franke; T Friedrich; J Lichey
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

6.  Body temperature modulates the effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit.

Authors:  M M Nieminen; M Hill; C G Irvin
Journal:  Agents Actions       Date:  1991-03

7.  Platelet-activating factor causes ventilation-perfusion mismatch in humans.

Authors:  R Rodriguez-Roisin; M A Félez; K F Chung; J A Barberà; P D Wagner; A Cobos; P J Barnes; J Roca
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

8.  Platelet activating factor mediates interleukin-2-induced lung injury in the rat.

Authors:  R Rabinovici; M D Sofronski; J F Renz; L M Hillegas; K M Esser; J Vernick; G Feuerstein
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

9.  Transcriptome analysis of ovary tissues from low- and high-yielding Changshun green-shell laying hens.

Authors:  Ren Mu; Yi-Yin Yu; Tuya Gegen; Di Wen; Fen Wang; Zhi Chen; Wen-Bin Xu
Journal:  BMC Genomics       Date:  2021-05-14       Impact factor: 3.969

10.  Bleomycin-induced lung injury in the rat: effects of the platelet-activating factor (PAF) receptor antagonist BN 52021 and platelet depletion.

Authors:  T W Evans; R J McAnulty; D F Rogers; K F Chung; P J Barnes; G J Laurent
Journal:  Environ Health Perspect       Date:  1990-04       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.